Status: Active
Supira Medical
- Status Current
- Sector Heart Failure
- Year Invested 2020
- HQ Campbell, CA, United States
- Clinical Activities Brazil, Paraguay
- Lead Partners Frederik Groenewegen
- David Thompson
Website supiramedical.com/
Percutaneous heart pump for high risk PCI and cardiogenic shock patients
Percutaneous ventricular assist devices are used during stent placement or angioplasty to provide mechanical support for high-risk patients with severe coronary artery disease or comorbidities. Additionally, pVADs are used to treat patients suffering from cardiogenic shock (CS), a condition that can occur following a severe heart attack and is associated with a high rate of morbidity as a patient's heart is suddenly too weak to adequately pump blood to vital organs.